1. Home
  2. RCEL vs AMTD Comparison

RCEL vs AMTD Comparison

Compare RCEL & AMTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • AMTD
  • Stock Information
  • Founded
  • RCEL N/A
  • AMTD 2003
  • Country
  • RCEL United States
  • AMTD France
  • Employees
  • RCEL N/A
  • AMTD N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • AMTD
  • Sector
  • RCEL Health Care
  • AMTD
  • Exchange
  • RCEL Nasdaq
  • AMTD Nasdaq
  • Market Cap
  • RCEL 107.8M
  • AMTD 93.9M
  • IPO Year
  • RCEL N/A
  • AMTD 2019
  • Fundamental
  • Price
  • RCEL $3.42
  • AMTD $1.00
  • Analyst Decision
  • RCEL Buy
  • AMTD
  • Analyst Count
  • RCEL 5
  • AMTD 0
  • Target Price
  • RCEL $11.80
  • AMTD N/A
  • AVG Volume (30 Days)
  • RCEL 260.2K
  • AMTD 937.0K
  • Earning Date
  • RCEL 11-06-2025
  • AMTD 10-20-2025
  • Dividend Yield
  • RCEL N/A
  • AMTD N/A
  • EPS Growth
  • RCEL N/A
  • AMTD N/A
  • EPS
  • RCEL N/A
  • AMTD 0.76
  • Revenue
  • RCEL $74,884,000.00
  • AMTD $67,032,000.00
  • Revenue This Year
  • RCEL $20.40
  • AMTD N/A
  • Revenue Next Year
  • RCEL $32.94
  • AMTD N/A
  • P/E Ratio
  • RCEL N/A
  • AMTD $1.35
  • Revenue Growth
  • RCEL 38.32
  • AMTD N/A
  • 52 Week Low
  • RCEL $3.37
  • AMTD $0.92
  • 52 Week High
  • RCEL $14.16
  • AMTD $1.65
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 28.06
  • AMTD 41.46
  • Support Level
  • RCEL $3.88
  • AMTD $1.00
  • Resistance Level
  • RCEL $3.91
  • AMTD $1.65
  • Average True Range (ATR)
  • RCEL 0.23
  • AMTD 0.11
  • MACD
  • RCEL -0.05
  • AMTD -0.01
  • Stochastic Oscillator
  • RCEL 0.00
  • AMTD 0.02

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.

Share on Social Networks: